Oniria Therapeutics
Pre-clinicalModulating cell dormancy to overcome cancer persistence
Founded
2020
Focus
Oncology
About
Modulating cell dormancy to overcome cancer persistence
Funding History
1Total raised: $4M
Seed$4MAsabys PartnersSep 15, 2022
Company Info
TypePrivate
Founded2020
LocationBarcelona, Spain
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile